Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBDRx was a Colorado-based hemp and cannabinoid company focused on cultivation, extraction, processing, and wholesale distribution of CBD-rich hemp products for wellness, nutraceutical, pharmaceutical, and animal-health markets. The company described itself as a producer of proprietary broad-spectrum hemp strains and medicinal-grade hemp oils and finished products. Its business appears to have centered on commercial hemp-derived cannabinoid products rather than a traditional drug-development pipeline. CBDRx was active as a standalone company in the mid-2010s, but the brand no longer appears to operate independently and is best understood as a historical cannabinoid-health company that was absorbed into the broader Charlotte's Web ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBDRx.